Wayfinder Biosciences

Wayfinder Biosciences is a privately held company located in Seattle, Washington. The company employs 12 people and generates revenue exceeding $10,000. Wayfinder Biosciences focuses on the development of a platform designed to discover RNA-targeting small molecules. These molecules are intended to treat a range of conditions including genetic diseases, neurodegeneration, and cancer. The company's platform combines a proprietary high-throughput screening system with machine learning models and unique datasets to expedite the development of drugs for targets that have been considered previously undruggable. Their innovative approach aims to accelerate the drug discovery process, bringing new treatments to patients more efficiently. For more information about Wayfinder Biosciences and its groundbreaking work, please visit their website at wayfinderbio.com.